학술논문
632P Predictive value of C-reactive protein (CRP) in microsatellite-stable (MSS) metastatic colorectal cancer (mCRC) patients given first-line alternating short-course oxaliplatin-based chemotherapy (FLOX) and nivolumab
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S449-S449
Subject
Language
ISSN
0923-7534